CooperCompanies announces FDA-approved MiSight 1 Day contact lens
It is the first and only soft contact lens proven to slow myopia progression in children aged 8-12.
See the latest news and media coverage for CooperCompanies. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global medical device company for vision and reproductive health
coopercos.comLast updated
In short: CooperCompanies grew revenue to over $4 billion in 2025, raised 2026 guidance, and appointed Colleen Jay as the new Board Chair.
It is the first and only soft contact lens proven to slow myopia progression in children aged 8-12.
The report includes first-time Scope 3 greenhouse gas emissions disclosure and expanded performance metrics.
Appointment effective July 1, 2026. Keel, CEO of Envista, joins Audit Committee. His medical device leadership experience aids strategy execution.
This CooperVision program reduces carbon impact in MyDay® products through sustainable materials, process improvements, and Plastic Bank partnership.
Cooper Companies (COO) Analyst Rating Update On October 5, 2023, UBS, through analyst Patrick Wood,...
The Cooper Companies is set to report Q3 earnings, with analysts expecting a marginal year-over-year...
Cooper Companies Inc (NASDAQ:COO) is one of the best stocks to buy according to Billionaire Barry Rosenstein. This stock is backed by 49 hedge funds...
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily...
Track CooperCompanies and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.